Polymeropoulos Mihael Hristos (CIK 0001355537)

Latest company ownership

Shares held
2,335,731
Last filed at
Aug 8, 2025
Confidence Score
54.3
2025Q4
Confidence Score History
2010Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 7, 2025 Aug 8, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $41.5K
May 21, 2025 May 21, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $44K
May 16, 2025 May 19, 2025 Vanda Pharmaceuticals Inc. CEO Buy 72.5 +20,000 0.87% ✗ $84.5K
Mar 6, 2025 Mar 6, 2025 Vanda Pharmaceuticals Inc. CEO Buy 65.0 +10,000 0.44% ✗ $50.2K
Mar 5, 2025 Mar 5, 2025 Vanda Pharmaceuticals Inc. CEO Buy 65.0 +10,000 0.44% ✗ $50.2K
Mar 1, 2025 Mar 4, 2025 Vanda Pharmaceuticals Inc. CEO Sell 40.0 -85,999 -3.64% ✗ $409.9K
Feb 28, 2025 Feb 28, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $47.6K
Feb 27, 2025 Feb 27, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $47.6K
Feb 26, 2025 Feb 26, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $47.7K
Feb 25, 2025 Feb 25, 2025 Vanda Pharmaceuticals Inc. CEO Buy 61.3 +10,000 0.43% ✗ $44.6K
Mar 4, 2024 Mar 6, 2024 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -55,172 -2.86% ✗ $231.3K
Mar 2, 2023 Mar 6, 2023 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -44,964 -2.95% ✗ $280.6K
Dec 5, 2022 Dec 7, 2022 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -95,900 -3.33% ✗ $1M
Feb 28, 2022 Mar 2, 2022 Vanda Pharmaceuticals Inc. CEO Sell 92.5 +77,904 6.11% ✗ $414K
Nov 30, 2021 Dec 2, 2021 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -96,200 -3.67% ✗ $1.6M
Mar 8, 2021 Mar 9, 2021 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -175,000 -12.54% ✗ $3.2M
Mar 1, 2021 Mar 3, 2021 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -22,685 -1.60% ✗ $416.9K
Dec 11, 2020 Dec 15, 2020 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -125,252 -3.12% ✗ $1.6M
Mar 2, 2020 Mar 4, 2020 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -15,580 -1.20% ✗ $166.8K
Jan 2, 2020 Jan 6, 2020 Vanda Pharmaceuticals Inc. CEO Sell 32.5 -9,467 -0.76% ✗ $151.5K
Dec 11, 2019 Dec 13, 2019 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -142,409 -5.45% ✗ $2.4M
May 17, 2019 May 21, 2019 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -217,515 -5.67% ✗ $3.3M
Mar 1, 2019 Mar 4, 2019 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -44,666 -3.65% ✗ $872.2K
Dec 24, 2018 Jan 4, 2019 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -19,236 -1.63% ✗ $401.7K
Feb 28, 2018 Mar 2, 2018 Vanda Pharmaceuticals Inc. CEO Sell 42.5 -966 -0.08% ✗ $1.1M
Dec 28, 2017 Jan 4, 2018 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -201,760 -5.72% ✗ $2.9M
Jan 3, 2017 Jan 5, 2017 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -23,330 -2.67% ✗ $361.2K
Jan 4, 2016 Jan 6, 2016 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -21,353 -2.48% ✗ $191.3K
Sep 9, 2015 Sep 11, 2015 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -131,739 -7.66% ✗ $1.7M
May 21, 2015 May 26, 2015 Vanda Pharmaceuticals Inc. CEO Sell 17.5 -186,395 -12.33% ✗ $1.9M
Mar 10, 2015 Mar 12, 2015 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -21,900 -3.84% ✗ $230.6K
Feb 5, 2015 Feb 9, 2015 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -24,947 -4.52% ✗ $281.4K
Feb 18, 2014 Feb 20, 2014 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -17,772 -3.41% ✗ $239.2K
Nov 19, 2013 Nov 21, 2013 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -8,928 -1.86% ✗ $107.8K
Feb 14, 2013 Feb 19, 2013 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -16,836 -3.56% ✗ $66.5K
Feb 16, 2012 Feb 21, 2012 Vanda Pharmaceuticals Inc. CEO Sell 22.5 -11,350 -2.58% ✗ $53.3K
Aug 22, 2011 Feb 13, 2012 Vanda Pharmaceuticals Inc. CEO Buy 87.5 +10,000 2.51% ✗ $53.5K
Aug 22, 2011 Aug 24, 2011 Vanda Pharmaceuticals Inc. CEO Buy 87.5 +10,000 2.63% ✗ $53.5K
Dec 9, 2010 Dec 13, 2010 Vanda Pharmaceuticals Inc. CEO Sell 20.0 -100,000 -20.83% ✗ $810.3K